Sara Dutta is a Principal Consultant, founder and digital partnerships leader with 16 years of experience at the intersection of life sciences and technology, focused on accelerating AI-driven drug discovery and development. She has led strategic R&D partnerships at Novo Nordisk, advised enterprise digital transformations at ZS and Dassault Systèmes, and translated cardiac computational modeling research from her PhD and FDA fellowship into practical regulatory and safety use cases. As founder of Ocilisni she now advises biotech and pharma on AI strategy, program delivery and commercial partnerships, with clients including the Allen Institute and Synthesize Bio. Fluent in French, Spanish and English and shaped by an international upbringing, she combines deep technical credibility in computational biology with hands-on dealmaking and program management across academia, industry and regulatory settings. An under-the-radar strength is her ability to bridge mechanistic cardiac models and modern LLM/knowledge-graph approaches to drive actionable target discovery and safety insights.
15 years of coding experience
2 years of employment as a software developer
PhD Computational Biology Department of Computer Science, PhD Computational Biology Department of Computer Science at University of Oxford
Beng Computer Science, Beng Computer Science at Imperial College London
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.